Profitability Ratios
| Ratio |
Value |
| GP Margin |
88.2% |
| EBIT Margin |
-10.2% |
| EBITDA Margin |
2.5% |
| Operating Margin |
5.3% |
| Pretax Margin |
-14.7% |
| Cont. Ops Margin |
-8.3% |
| Net Margin |
-8.3% |
| Bottom Line Margin |
-8.3% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.86 |
| Quick Ratio |
1.67 |
| Solvency Ratio |
0.025 |
| Cash Ratio |
0.62 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.18 |
| Forward PEG |
0.18 |
| Price/Book |
2.40 |
| Price/Sales |
2.43 |
| Price/FCF |
7.99 |
| Price/Op Cash Flow |
7.65 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.4652 |
| Debt/Equity |
1.2559 |
| Debt/Capital |
0.5567 |
| Long-Term Debt/Capital |
0.5006 |
| Financial Leverage |
2.70 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
1.55 |
| Operating Cash Flow Ratio |
0.605 |
| Operating Cash Flow/Sales |
31.8% |
| Free Cash Flow/Operating Cash Flow |
95.7% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
0.31 |
| Interest Coverage |
1.1506 |
| Short-Term Operating Cash Flow Coverage |
1.32 |
| Operating Cash Flow Coverage |
0.25 |
| Capital Expenditure Coverage |
23.08 |
| Dividend + Capital Expenditure Coverage |
23.08 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
69.98 |
| EPS |
-5.840 |
| Debt/Share |
92.1372 |
| Cash/Share |
40.04 |
| Book Value/Share |
70.81 |
| Tangible BV/Share |
-31.82 |
| Equity/Share |
70.81 |
| Operating Cash Flow/Share |
22.232 |
| Capital Expenditure/Share |
0.963 |
| FCF/Share |
21.268 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.567 |
| Earnings Before Tax/EBIT |
-2.801 |
| Price/Fair Value |
2.40 |
| Debt/Market Cap |
0.5168 |
| Effective Tax Rate |
43.3% |
| Enterprise Value Multiple |
132.76 |
JAZZ - Jazz Pharmaceuticals plc